Startup Funding Espresso – Customer Intimacy in Fundraising
[audio src="https://traffic.libsyn.com/secure/angelconnect/04.customer_intimacy_in_fundraising.mp3"][/audio]Customer Intimacy in Fundraising Hello, this is Hall T. Martin with the Startup Funding Espresso -- your daily shot of startup funding and investing. Customer intimacy is a strategy in which one builds a relationship with the customer about their care abouts and expectations. The more one knows about…
Startup Funding Espresso – Founders Who Got Lucky
[audio src="https://traffic.libsyn.com/secure/angelconnect/03.founders_who_got_lucky.mp3"][/audio]Founders Who Got Lucky Hello, this is Hall T. Martin with the Startup Funding Espresso -- your daily shot of startup funding and investing. Some founders get lucky and achieve a successful exit of their business. They were in the right place at the right time with the right…
Startup Funding Espresso – Your First Round Should Have an Investor-Friendly Valuation
[audio src="https://traffic.libsyn.com/secure/angelconnect/02.your_first_round_shoulf_have_an_investor_friendly_valuation.mp3"][/audio]Your First Round Should Have an Investor-Friendly Valuation Hello, this is Hall T. Martin with the Startup Funding Espresso -- your daily shot of startup funding and investing. In raising funding, the first round is always the hardest. Here's why it's so difficult: There's often no product or revenue…
Startup Funding Espresso – Mitigate the Risks
[audio src="https://traffic.libsyn.com/secure/angelconnect/01.mitigate_the_risks.mp3"][/audio]Mitigate the Risks Hello, this is Hall T. Martin with the Startup Funding Espresso -- your daily shot of startup funding and investing. In a pitch, founders focus on the opportunity while the investors focus on the risk. Founders who raise funding have successfully shown how they mitigate those…
Investor Connect: TEN Connect May 2026 – Part 3
In this episode of Investor Connect, we hear a pitch from Ethair on addressing the global opioid epidemic with ATX-1209, a neuromodulator designed to modulate the mu-opioid receptor by suppressing dependence signals while preserving analgesic benefit when used alongside opioids, with additional development plans for opioid use disorder and neonatal…